DE602004032382D1 - Gabapentin enthaltende pharmazeutische zubereitung - Google Patents

Gabapentin enthaltende pharmazeutische zubereitung

Info

Publication number
DE602004032382D1
DE602004032382D1 DE602004032382T DE602004032382T DE602004032382D1 DE 602004032382 D1 DE602004032382 D1 DE 602004032382D1 DE 602004032382 T DE602004032382 T DE 602004032382T DE 602004032382 T DE602004032382 T DE 602004032382T DE 602004032382 D1 DE602004032382 D1 DE 602004032382D1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparation
containing pharmaceutical
gabapentin
gabapentin containing
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004032382T
Other languages
English (en)
Inventor
Luca Rampoldi
Alessandro Grassano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of DE602004032382D1 publication Critical patent/DE602004032382D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE602004032382T 2003-12-09 2004-12-02 Gabapentin enthaltende pharmazeutische zubereitung Active DE602004032382D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002399A ITMI20032399A1 (it) 2003-12-09 2003-12-09 Composizione farmaceutica contenente gabapentina.
PCT/EP2004/053233 WO2005055993A2 (en) 2003-12-09 2004-12-02 Pharmaceutical preparation containing gabapentin

Publications (1)

Publication Number Publication Date
DE602004032382D1 true DE602004032382D1 (de) 2011-06-01

Family

ID=34674559

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004032382T Active DE602004032382D1 (de) 2003-12-09 2004-12-02 Gabapentin enthaltende pharmazeutische zubereitung

Country Status (21)

Country Link
US (2) US20080194687A1 (de)
EP (1) EP1699438B1 (de)
JP (1) JP5432433B2 (de)
CN (1) CN100508966C (de)
AT (1) ATE506052T1 (de)
AU (1) AU2004296561B2 (de)
BR (1) BRPI0417420B1 (de)
CA (1) CA2546476C (de)
DE (1) DE602004032382D1 (de)
DK (1) DK1699438T3 (de)
EA (1) EA012068B1 (de)
ES (1) ES2363503T3 (de)
HR (1) HRP20110346T1 (de)
IL (1) IL175764A (de)
IT (1) ITMI20032399A1 (de)
NZ (1) NZ547764A (de)
PL (1) PL1699438T3 (de)
PT (1) PT1699438E (de)
SI (1) SI1699438T1 (de)
WO (1) WO2005055993A2 (de)
ZA (1) ZA200604717B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8607620B2 (en) * 2007-10-02 2013-12-17 Shimadzu Corporation Preparative separation/purification system
USD657242S1 (en) 2010-01-14 2012-04-10 S.C. Johnson & Son, Inc. Container with nozzle
WO2017204582A1 (en) * 2016-05-27 2017-11-30 Hanmi Pharm. Co., Ltd. Pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof inhibiting growth of cancer cells and a stabilizer having low melting point
RU2731536C1 (ru) * 2019-07-30 2020-09-04 Общество С Ограниченной Ответственностью "Консорциум-Пик" Фармацевтические композиции, содержащие фенозановую кислоту
RU2736479C1 (ru) * 2019-07-30 2020-11-17 Общество С Ограниченной Ответственностью "Консорциум-Пик" Не содержащая наполнитель фармацевтическая композиция, содержащая фенозановую кислоту

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621097A (de) * 1961-08-05
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
JPS58214333A (ja) * 1982-06-04 1983-12-13 Dai Ichi Seiyaku Co Ltd 粒状物
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US5169645A (en) * 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties
US5078990A (en) * 1990-07-13 1992-01-07 Helene Curtis, Inc. Shampoos and conditioning shampoos having increased capacity for incorporation of conditioning agents and removal of hair soil
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
MX9707585A (es) * 1995-04-03 1997-12-31 Abbott Lab Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
AU9496798A (en) * 1997-09-19 1999-04-05 Shire Laboratories, Inc. Solid solution beadlet
CN100337687C (zh) 1998-05-15 2007-09-19 沃尼尔·朗伯公司 含有γ－氨基丁酸衍生物的固体组合物及其制备方法
IL125244A (en) 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7374779B2 (en) 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
EP1238662B1 (de) * 2001-03-07 2006-05-31 Dainippon Sumitomo Pharma Co., Ltd. Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
ITMI20011337A1 (it) 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio modificato del principio attivo
TWI312285B (en) * 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
WO2003082804A1 (en) 2002-03-28 2003-10-09 Synthon B.V. Venlafaxine besylate
AU2003267732A1 (en) * 2002-10-08 2004-05-04 Ranbaxy Laboratories Limited Gabapentin tablets and methods for their preparation

Also Published As

Publication number Publication date
EP1699438A2 (de) 2006-09-13
NZ547764A (en) 2009-09-25
WO2005055993A3 (en) 2006-05-26
ITMI20032399A1 (it) 2005-06-10
PL1699438T3 (pl) 2011-10-31
CN100508966C (zh) 2009-07-08
US8927017B2 (en) 2015-01-06
DK1699438T3 (da) 2011-08-15
JP2007513920A (ja) 2007-05-31
CA2546476C (en) 2012-01-31
JP5432433B2 (ja) 2014-03-05
US20080194687A1 (en) 2008-08-14
CN1889934A (zh) 2007-01-03
SI1699438T1 (sl) 2011-09-30
IL175764A (en) 2012-08-30
EA012068B1 (ru) 2009-08-28
AU2004296561B2 (en) 2009-02-26
EA200600939A1 (ru) 2006-12-29
CA2546476A1 (en) 2005-06-23
WO2005055993A2 (en) 2005-06-23
ATE506052T1 (de) 2011-05-15
BRPI0417420B1 (pt) 2021-10-13
ZA200604717B (en) 2007-03-28
BRPI0417420A (pt) 2007-03-06
AU2004296561A1 (en) 2005-06-23
US20110189272A1 (en) 2011-08-04
EP1699438B1 (de) 2011-04-20
IL175764A0 (en) 2008-04-13
ES2363503T3 (es) 2011-08-05
HRP20110346T1 (hr) 2011-06-30
PT1699438E (pt) 2011-07-05

Similar Documents

Publication Publication Date Title
AU2003265055A1 (en) Gprs signaling via sms messages
IT1316816B1 (it) Granulatore sommerso e procedimento per la granulazione di materiali termoplastici
IL168784A (en) Fused 1,3-dihydroimidazole ring compounds and pharmaceutical compositions comprising the same
HUP0203827A3 (en) Laser beam weldable thermoplastic molding materials
HK1064663A1 (en) Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
DK1486613T3 (da) Anvendelse af et bestemt udfyldningsmateriale i en kunstig græsbelægning, og en tilsvarende kunstig græsbelægning
NO20014035L (no) System for oral administrasjon av medikament
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
ZA200604717B (en) Pharmaceutical preparation containing gabapentin
DE60314265D1 (de) Pharmazeutische zusammensetzungen mit modafinil
AU2003266199A1 (en) Method for granulating plastics
ATE552826T1 (de) Pharmazeutische formulierungen mit clopidogrel
BR0207915B1 (pt) processo para a preparação de uma formulação sólida de uma substância agroquímica
AU2003242473A1 (en) Cycloolefin copolymer formed by ring-opening polymerization, process for producing the same, and optical material
ITRM20030128A0 (it) Dispositivo per l'applicazione e la termoretrazione di etichette in materiale plastico, e procedimento per l'applicazione di dette etichette
DE60237689D1 (de) Thermoplastische polymerzusammensetzung
ATE412405T1 (de) Pharmazeutische zusammensetzung mit modifiziertem träger
AU2002368127A1 (en) Plastic photochromic lens and method for preparation thereof
AR034435A1 (es) Agentes terapeuticos.
DK1151746T3 (da) Mikro-kapsler til vedvarende frigivelse af lægemidler
WO2004041206A3 (en) Waxy matrix dosage forms
AU2003264075A8 (en) Active fusion proteins and method for the production thereof
ATE330623T1 (de) Stabile pharmazeutische zusammensetzung mit erythropoietin
HUP0201233A2 (en) Pharmaceutical composition in the form of granulate and its preparation by melt granulation
TW200718661A (en) Method for cutting glass